14/10/2026 23:07
|
Medical, Health & Aged Care
− TAK-881 met its primary endpoint, demonstrating pharmacokinetic comparability to HYQVIA® in patients 16 years and older
− TAK-881 may shorten infusion times and offer the opportunity for fewer...